LONG FACTOR CERTIFICATE - ARGENX SE Stock

Certificat

Z4L7H

DE000GP92NQ6

Market Closed - Euronext Paris 12:30:01 2024-05-31 pm EDT
0.02 EUR -33.33% Intraday chart for LONG FACTOR CERTIFICATE - ARGENX SE
1 month-62.50%
3 months-83.33%
Date Price Change
24-05-31 0.03 -.--%
24-05-30 0.03 -25.00%
24-05-29 0.04 +33.33%
24-05-28 0.03 -.--%
24-05-24 0.03 -.--%

Real-time Euronext Paris

Last update May 31, 2024 at 12:30 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying ARGENX SE
Issuer Goldman Sachs
Z4L7H
ISINDE000GP92NQ6
Date issued 2023-07-17
Strike 295.2
Maturity Unlimited
Parity 1741.83 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 79.69
Lowest since issue 0.02

Company Profile

argenx SE is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx SE aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx SE is evaluating efgartigimod in multiple serious autoimmune diseases, and cusatuzumab in hematological cancers in collaboration with Janssen. argenx SE is also advancing several earlier stage experimental medicines within its therapeutic franchises. argenx SE has offices in Belgium, the United States, and Japan.
Sector
-
More about the company

Ratings for argenx SE

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: argenx SE

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
340.7 EUR
Average target price
436.6 EUR
Spread / Average Target
+28.14%
Consensus
  1. Stock Market
  2. Certificates
  3. Z4L7H Certificat